Article
Systematically Characterizing A-to-I RNA Editing Neoantigens in Cancer
10 Dec 2020
Abstract excerpt
A-to-I RNA editing can contribute to the transcriptomic and proteomic diversity of many diseases including cancer. It has been reported that peptides generated from RNA editing could be naturally presented by human leukocyte antigen (HLA) molecules and elicit CD8+ T cell activation. However, a systematical characterization of A-to-I RNA editing neoantigens in cancer is still lacking. Here, an integrated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
